Psychiatric News
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Article
Psychiatric News May 6, 2005
Volume 40 Number 9
© 2005 American Psychiatric Association
p. 29


Clinical & Research News

`When There's No Money To Be Made...'

Despite proven efficacy, light therapy appears to be a marginal treatment in the eyes of many clinicians.


"I believe the availability of light therapy is hit or miss," said Robert Golden, M.D., author of a meta-analysis of studies of light therapy showing it to be highly effective in treatment of mood disorders (see above story). "Some communities may not have clinicians who are trained in this modality. It is a relatively new treatment compared with psychotherapy or pharmacotherapy, and I would predict that the number of lectures and symposia focused on it at the APA annual meeting is quite small, compared with those addressing other treatments.

"In my opinion, more education is clearly indicated, especially as the evidence base supporting its use and defining the standard treatment parameters moves forward," Golden said.

Norman Rosenthal, M.D., who has done more than anyone to advance the use of light therapy and the understanding of seasonal affective disorder (SAD), concurred.

"I know of no published data that speak to the frequency with which clinicians prescribe light therapy, but my impression, based on many years of working with SAD patients, is that clinicians often just don't think about it as a legitimate therapy or else fail to prescribe light for other reasons," he told Psychiatric News.

"It is certainly an area in which clinicians need more education," Rosenthal added. "When it comes to pharmaceutical treatments of depression and other conditions, physicians are constantly being educated by pharmaceutical representatives and at industry-sponsored dinners and symposia. But when there is no money to be made, no such opportunities for education arise, and public agencies would do well to step in and fill the vacuum."


Related Article:

Light Therapy Kept in Dark Despite Effectiveness
Mark Moran
Psychiatr News 2005 40: 29. [Full Text]




Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Article


Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org